טוען...
Optimized TrkB Agonist Ameliorates Alzheimer’s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase
[Image: see text] BDNF/TrkB neurotropic pathway, essential for neural synaptic plasticity and survival, is deficient in neurodegenerative diseases including Alzheimer’s disease (AD). Our previous works support that BDNF diminishes AD pathologies by inhibiting delta-secretase, a crucial age-dependent...
שמור ב:
| הוצא לאור ב: | ACS Chem Neurosci |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Chemical Society
2021
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8269693/ https://ncbi.nlm.nih.gov/pubmed/34106682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.1c00181 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|